Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 85501-85550 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05284552
Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer
PHASE2Recruiting
40 participants
Started: Jul 12, 2022 · Completed: Dec 31, 2026
1 condition5 sponsors8 locations
NCT05487170
A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1)
PHASE1/PHASE2Recruiting
32 participants
Started: Jul 12, 2022 · Completed: Sep 1, 2025
2 conditions1 sponsor5 locations
NCT05165407
Sintilimab Combined With IBI310 and Surufatinib for the Treatment of G3-NET and NEC (NESSIE)
PHASE2Recruiting
30 participants
Started: Jul 12, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor2 locations
NCT05679570
Satralizumab in the Treatment of Pulmonary Arterial Hypertension (SATISFY-JP Trial)
PHASE2Active, not recruiting
20 participants
Started: Jul 12, 2022 · Completed: Jun 30, 2026
1 condition4 sponsors9 locations
NCT05153967
Cooperative Assessment of Late Effects for SCD Curative Therapies
N/ARecruiting
750 participants
Started: Jul 12, 2022 · Completed: Feb 28, 2026
4 conditions6 sponsors5 locations
NCT05402033
Cancer Clinical Trials Financial Reimbursement Program
N/ARecruiting
1,200 participants
Started: Jul 12, 2022 · Completed: Jun 1, 2027
1 condition2 sponsors1 location
NCT05305794
"Effect of Weekly GLP1 Agonist Treatment in double Diabetes"
PHASE3Recruiting
76 participants
Started: Jul 12, 2022 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05752604
Impact of Conventional Treatments and Clinical Variables on Thyroid Cancer
N/ARecruiting
3,000 participants
Started: Jul 12, 2022 · Completed: Mar 8, 2042
1 condition1 sponsor1 location
NCT05481827
ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study
PHASE2Enrolling by invitation
225 participants
Started: Jul 12, 2022 · Completed: Jun 2, 2028
1 condition2 sponsors32 locations
NCT05470218
Leucine, MTOR and Athero
NAActive, not recruiting
10 participants
Started: Jul 12, 2022 · Completed: Aug 14, 2026
1 condition2 sponsors1 location
NCT06456411
Functional Near-Infrared Spectroscopy and Virtual Reality Relaxation Programs for Pain Management in Patients With Cancer
NARecruiting
430 participants
Started: Jul 12, 2022 · Completed: Jul 12, 2026
3 conditions1 sponsor1 location
NCT05464251
Prospective Analysis of Spinal Epidural Abscess
N/ARecruiting
200 participants
Started: Jul 12, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06310343
ADAs to Alemtuzumab
N/AActive, not recruiting
15 participants
Started: Jul 12, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT05452226
Neuromuscular Electrical Stimulation in COPD/Community Acquired Pneumonia
NARecruiting
8 participants
Started: Jul 12, 2022 · Completed: Dec 30, 2025
2 conditions1 sponsor1 location
NCT05474378
B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme
PHASE1Recruiting
39 participants
Started: Jul 12, 2022 · Completed: Aug 31, 2026
1 condition3 sponsors1 location
NCT05795894
Qualitative Study of Suicidal Recrudescence Among Adolescents in November 2021
N/ARecruiting
10 participants
Started: Jul 12, 2022 · Completed: Mar 31, 2024
2 conditions1 sponsor1 location
NCT05594797
Human BCMA Targeted T Cells Injection(BCMA CAR-T)for Subjects With R/R MM
PHASE2Recruiting
100 participants
Started: Jul 12, 2022 · Completed: Jul 31, 2027
1 condition3 sponsors2 locations
NCT06579573
ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.
PHASE3Recruiting
15 participants
Started: Jul 12, 2022 · Completed: Jan 31, 2027
1 condition1 sponsor25 locations
NCT05438953
Follow-up of People at Risk of Monkeypox Infection: a Prospective Cohort Study
NAActive, not recruiting
164 participants
Started: Jul 12, 2022 · Completed: Oct 31, 2024
2 conditions1 sponsor1 location
NCT05989178
Prospective Recurrent Pregnancy Loss Registry
N/ARecruiting
3,000 participants
Started: Jul 12, 2022 · Completed: Dec 31, 2032
1 condition1 sponsor1 location
NCT05408143
An Enhanced Home-Based Telemedicine Program Using Remote Examination Devices for Children With Medical Complexity
NARecruiting
300 participants
Started: Jul 12, 2022 · Completed: Nov 1, 2025
1 condition2 sponsors1 location
NCT05747365
Role of Endocrine Disruptors in Thyroid Cancer
N/ARecruiting
222 participants
Started: Jul 12, 2022 · Completed: Jul 31, 2025
2 conditions1 sponsor1 location
NCT05301673
ADHD Remote Technology Study of Cardiometabolic Risk Factors and Medication Adherence
N/AActive, not recruiting
600 participants
Started: Jul 12, 2022 · Completed: Mar 31, 2025
3 conditions14 sponsors2 locations
NCT05435313
Fruquintinib Combined With Tislelizumab and HAIC in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard Therapy
PHASE2Active, not recruiting
39 participants
Started: Jul 12, 2022 · Completed: Feb 29, 2024
1 condition1 sponsor1 location
NCT05460533
A Second Infusion (Early Reinfusion) of Tisagenlecleucel in Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia(B-ALL)
PHASE2Active, not recruiting
30 participants
Started: Jul 12, 2022 · Completed: Jul 31, 2026
1 condition2 sponsors6 locations
NCT05245695
Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)
N/ARecruiting
1,200 participants
Started: Jul 12, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor10 locations
NCT05419089
The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)
PHASE2Recruiting
83 participants
Started: Jul 12, 2022 · Completed: Jun 30, 2027
1 condition1 sponsor2 locations
NCT05458284
The Effect of Acupuncture on Nerve Pain Caused by Taxane (Chemotherapy) Treatment
PHASE2Active, not recruiting
80 participants
Started: Jul 11, 2022 · Completed: Jul 31, 2026
2 conditions2 sponsors7 locations
NCT05467540
SPINERY™ A Novel Radio-Frequency Tumor Ablation Device Study
NAActive, not recruiting
52 participants
Started: Jul 11, 2022 · Completed: Nov 30, 2024
1 condition1 sponsor5 locations
NCT05263596
SARCOPEDIA - Sarcopenia Diagnostics in Aging Medicine
NARecruiting
120 participants
Started: Jul 11, 2022 · Completed: Oct 30, 2024
3 conditions1 sponsor1 location
NCT05245201
Clinical Decision Support for PrEP
NAActive, not recruiting
4 participants
Started: Jul 11, 2022 · Completed: Aug 31, 2027
2 conditions5 sponsors3 locations
NCT05148715
Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY)
PHASE2Active, not recruiting
414 participants
Started: Jul 11, 2022 · Completed: Jan 31, 2026
3 conditions2 sponsors9 locations
NCT05111899
Leading Advancements in the Uptake of Newborn Community Health
NAActive, not recruiting
316 participants
Started: Jul 11, 2022 · Completed: Apr 1, 2024
3 conditions3 sponsors1 location
NCT05574868
Rigicon Infla10® Three-Piece Inflatable Penile Prosthesis (ERASE ED)
NARecruiting
177 participants
Started: Jul 11, 2022 · Completed: May 21, 2026
1 condition1 sponsor3 locations
NCT06582511
Evaluating Metabolic Changes Induced by PhotoBioModulation Through Spectrally Resolved Autofluorescence in Dry Age-Related Macular Degeneration Patients
N/AActive, not recruiting
30 participants
Started: Jul 11, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05452889
PET Image in PAH Patients
EARLY_PHASE1Recruiting
71 participants
Started: Jul 11, 2022 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT05536531
NMES Role to Prevent Respiratory Muscle Weakness in Critically Ill Patients and Its Association to Changes in Myokines.
NARecruiting
32 participants
Started: Jul 11, 2022 · Completed: Feb 28, 2025
3 conditions1 sponsor1 location
NCT06800469
Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer
NARecruiting
30 participants
Started: Jul 11, 2022 · Completed: Jul 1, 2025
1 condition1 sponsor1 location
NCT05383092
Adapted Physical Activity for Children Treated With Cancer and Insulin Sensitivity
NARecruiting
60 participants
Started: Jul 11, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05270213
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
PHASE1Recruiting
164 participants
Started: Jul 11, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor14 locations
NCT05164055
Avalglucosidase Alfa French Post-trial Access for Participants With Pompe Disease (PTA Avalglucosidase)
PHASE4Active, not recruiting
17 participants
Started: Jul 11, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor11 locations
NCT05568966
Collection of Blood Samples for New Diagnostic Devices 2
NARecruiting
20,000 participants
Started: Jul 11, 2022 · Completed: Aug 20, 2026
5 conditions1 sponsor7 locations
NCT05106036
Preventing Cognitive Decline by Reducing BP Target Trial
NARecruiting
4,000 participants
Started: Jul 11, 2022 · Completed: Aug 31, 2025
3 conditions4 sponsors1 location
NCT05266066
Ventilator-associated Tracheobronchitis Initiative to Conduct Antibiotic Evaluation
NARecruiting
590 participants
Started: Jul 11, 2022 · Completed: Dec 1, 2026
2 conditions7 sponsors16 locations
NCT05217446
A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer
PHASE2Active, not recruiting
107 participants
Started: Jul 11, 2022 · Completed: Jan 26, 2027
1 condition4 sponsors64 locations
NCT05467215
Can Brief Exposure to Hyperoxia Improve Function After Chronic Spinal Cord Injury?
EARLY_PHASE1Recruiting
25 participants
Started: Jul 11, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05463289
ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
NARecruiting
500 participants
Started: Jul 11, 2022 · Completed: Oct 29, 2025
3 conditions3 sponsors1 location
NCT04496817
Enriched Eggs for Retina Health in Type 2 Diabetes
NARecruiting
60 participants
Started: Jul 11, 2022 · Completed: Sep 1, 2024
2 conditions2 sponsors1 location
NCT05181891
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
PHASE2Recruiting
205 participants
Started: Jul 11, 2022 · Completed: May 1, 2026
2 conditions1 sponsor1 location
NCT05382572
Pulmonary Fibrosis Foundation Community Registry
N/ARecruiting
10,000 participants
Started: Jul 11, 2022 · Completed: Jul 1, 2027
4 conditions2 sponsors1 location